Skip to content
Stop using now Drug recall · FDA · Published April 21, 2014

Hospira Recalls Marcaine Injections Due to Metal Particles

Hospira recalls 85,680 vials of Marcaine injection due to visible metal particles. Check lot 34-440-DD before use.

🇺🇸 FDA recall #D-1358-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 85,680 single-dose vials of Marcaine (bupivacaine HCl) injection because they may contain discolored solution with visible metal particles embedded in the glass or floating in the liquid. This recall affects a Class I product distributed nationwide. The specific lot involved is 34-440-DD, which expired in October 2015. Read more at govinfonow.com/recall/46118-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25.

Source Summary by GovInfoNow · govinfonow.com/recall/46118-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1358-2014

Cite this page

“Hospira Recalls Marcaine Injections Due to Metal Particles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46118-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25. Based on FDA recall #D-1358-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1358-2014%22&limit=1).

The FDA announced on April 21, 2014, that Hospira Inc. voluntarily recalled Marcaine (bupivacaine HCl) injection vials due to the presence of particulate matter. The recall affects 85,680 single-dose vials distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Marcaine Injection Vials
  • NDC: 0409-1559-10
  • Lot #: 34-440-DD
  • Expiration: 10/15
  • Quantity: 85,680 vials

The hazard

The recall was initiated following a confirmed customer complaint of a discolored solution with visible metal particles embedded in the glass vial and visible in the solution. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Hospira Infant Dextrose Injection Recall (April 21, 2017), Hospira Fentanyl Injection Recall (Nov. 1, 2016), and Hospira DOBUTamine Injection Recall (Aug. 15, 2016). Other recent recalls of similar products include GE Healthcare Omnipaque Injection Recall (March 24, 2026), GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026), and B. Braun Medical Lactated Ringer's Injection Recall (April 28, 2026).

How to tell if you have this one

Look for single-dose vials labeled 'Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg)' manufactured by Hospira, Inc. Check the label for NDC 0409-1559-10 and Lot #34-440-DD with an expiration date of 10/15.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Recalled Vials

    Do not use any vials matching the described lot number or NDC due to the risk of metal particles.

  2. Contact Healthcare Provider

    If you have used this product, consult your healthcare provider immediately for guidance on potential exposure.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.9 years after the firm started it.

1. Firm started the recall: Apr 21, 201412. FDA classified it Class I: Jun 5, 201423. Published in FDA’s Enforcement Report: Jun 11, 201434. FDA terminated the recall: Mar 16, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC for the affected product?

The National Drug Code (NDC) is 0409-1559-10.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1358-2014 (April 21, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1358-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA